SPR Therapeutics scores $37M for pain relief tool and other digital health fundings
Summary
SPR plans to use the cash to speed the commercial use of its pain-relief device, the SPRINT Peripheral Nerve Stimulation System, fund clinical studies and invest in new technology. “This additional funding will allow us to accelerate the already strong adoption we are seeing of our SPRINT PNS System within the interventional pain management community,” said Maria Bennett, CEO, president and founder of SPR Therapeutics, in a statement. Insurights, an AI-enabled platform that helps users navigate their health benefits, announced Tuesday it raised $22 million in seed funding. The company, formerly known as Knowtions Research, chose Taiwan as a pilot market for its product, and plans to expand into Japan, South Korea and Southeast Asia using the influx of capital. With more data and improved predictive accuracy, we can help insurers make better risk decisions that transform customer experience for the next billion people.” Lydia raised $5 million in Series A funding in 2018.